Alan Stewart Stock: price and insider trades · United Kingdom
1 insider bought €30k of shares over the last 90 days, the latest by Haleon plc, filed 30 Oct 2026.
Alan Stewart: what insiders have been doing
Every trade that managers of Alan Stewart disclose to RNS (LSE) is tracked on this page. The company sits in the Health Care sector and is based in Weybridge, United Kingdom. 1 insider has disclosed 3 filings since 2 November 2025.
Every open-market trade in the period is a purchase: 1 purchase worth €30k, from 1 insider, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants. One trade stands out by size: a purchase of €30k from Haleon plc, disclosed on 30 October 2026.
The last insider purchase was made public on 30 October 2026, 9 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The legal deadline for notifying a trade is three business days (UK MAR).
Across the 832 companies tracked on its exchange, the median is 6 filings; at 3 filings, this issuer sits below that mark. The full history, which starts in 2022, counts 1 purchase against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Alan Stewart Buy (bullish), based on 17 analysts. Average price target: £4.18.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 7,670 shares@ £3.242London Stock Exchange (XLON)ISIN GB00BMX86B70RNS:9853470Canonical exit: 28 Jan 2027 (T+90)
- 242 shares@ £3.37860.0000% mcap7.8% of flowLondon Stock Exchange (XLON)ISIN GB00BMX86B70RNS:9780109
- 498 shares@ £3.31050.0000% mcap15.6% of flowLondon Stock Exchange (XLON)ISIN GB00BMX86B70RNS:cbf36308-8596-49ac-9179-3a944cb4d1ec
- 7,919 shares@ £2.2728100.0% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4621992-0
- 7,919 shares@ £2.272897.3% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4621992-1
- 7,919 shares@ £2.272897.3% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4621992-2
- 78 shares@ £3.191.4% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4611023-0
- 78 shares@ £3.191.4% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4611023-1
- 88 shares@ £2.821.4% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4577135-0
- 88 shares@ £2.821.4% of flowLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4577135-1
- 1,033 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4448915-0
- 379 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4448915-1
- 837 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4448915-2
- 386 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4448915-3
- 937 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4448915-4
- 71,800 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447346
- 10,464 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-0
- 17,864 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-1
- 21,278 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-2
- 17,994 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-3
- 44,376 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-4
- 1,376 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-5
- 104 sharesLondon Stock ExchangeISIN GB00BMX86B70FCA-NSM:4447328-6
- 121,929 sharesNew York Stock ExchangeFCA-NSM:4447341-0
- 5,681 sharesNew York Stock ExchangeFCA-NSM:4447341-1
25 of 27 declarations
About Alan Stewart
Alan Stewart is a company operating in the healthcare and pharmaceutical sector, listed on the London Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
